01 1Corden PharmaChem nv
01 1Bufexamac
01 1Germany
Registration Number : 218MF10882
Registrant's Address : Industrypark Roosveld 2, B6, 3400 Landen, Belgium
Initial Date of Registration : 2006-11-10
Latest Date of Registration : 2006-11-10
17
PharmaCompass offers a list of Bufexamac API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bufexamac manufacturer or Bufexamac supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bufexamac manufacturer or Bufexamac supplier.
PharmaCompass also assists you with knowing the Bufexamac API Price utilized in the formulation of products. Bufexamac API Price is not always fixed or binding as the Bufexamac Price is obtained through a variety of data sources. The Bufexamac Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A J3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of J3, including repackagers and relabelers. The FDA regulates J3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. J3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of J3 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A J3 supplier is an individual or a company that provides J3 active pharmaceutical ingredient (API) or J3 finished formulations upon request. The J3 suppliers may include J3 API manufacturers, exporters, distributors and traders.
click here to find a list of J3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The J3 Drug Master File in Japan (J3 JDMF) empowers J3 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the J3 JDMF during the approval evaluation for pharmaceutical products. At the time of J3 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of J3 suppliers with JDMF on PharmaCompass.
